The properties of cMLVs, such as improved stability and sustained release of drugs, enable the nanoparticles to sufficiently accumulate at tumor sites, subsequently entering tumor cells via endocytosis to release therapeutics, thus potentially bypassing the P-gp pathway to enhance cellular retention of therapeutics. Here, PGP is linked to neoplasm.